KM-819

N/A

Report date: 2022/04/18 10:03:16
NME

Base Information

Drug NameKM-819
Drug Alias NameKM-819KR-33493
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAS-associated factor 1 inhibitors
TargetsFAS-associated factor 1
Therapy Area/IndicationsParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKainos Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesFAScinate Therapeutics Inc
Inactive CompaniesKainos Medicine Inc
Active IndicationsParkinson Disease
Inactive IndicationsMultiple System Atrophy

Other Information

ATC CodeN/A
Related LinksN/A